47783-646-01 |
47783-646 |
HUMAN PRESCRIPTION DRUG |
TAKHZYRO |
lanadelumab-flyo |
SOLUTION |
SUBCUTANEOUS |
20220208 |
N/A |
BLA |
BLA761090 |
Takeda Pharmaceuticals America, Inc. |
LANADELUMAB |
300 mg/2mL |
1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS |
47783-645-01 |
47783-645 |
HUMAN PRESCRIPTION DRUG |
TAKHZYRO |
lanadelumab-flyo |
SOLUTION |
SUBCUTANEOUS |
20230203 |
N/A |
BLA |
BLA761090 |
Takeda Pharmaceuticals America, Inc. |
LANADELUMAB |
150 mg/mL |
1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS |
47783-644-01 |
47783-644 |
HUMAN PRESCRIPTION DRUG |
TAKHZYRO |
lanadelumab-flyo |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20180824 |
N/A |
BLA |
BLA761090 |
Takeda Pharmaceuticals America, Inc. |
LANADELUMAB |
300 mg/2mL |
1 VIAL, GLASS in 1 CARTON (47783-644-01) / 5 mL in 1 VIAL, GLASS |